Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Comprehensive Assessment of Neurodegeneration and Dementia Study

NCT03402919 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT03402919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03402919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Comprehensive Assessment of Neurodegeneration and Dementia Study
Lead sponsor
McGill University
Phase
Observational
Overall status
Recruiting
Start date
June 30, 2016
Completion date
December 31, 2029
Enrollment
1,573 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease (ad), cognitively unimpaired, dementia, frontotemporal dementia (ftd), lewy body disease(lbd), mild cognitive impairment (mci), mixed dementia, parkinson's disease (pd), subjective cognitive decline (scd), subjective cognitive impairment